These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1654454)

  • 1. Neutralizing antibodies induced by recombinant vaccinia virus expressing varicella-zoster virus gpIV.
    Vafai A; Yang WN
    J Virol; 1991 Oct; 65(10):5593-6. PubMed ID: 1654454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system.
    Yao Z; Jackson W; Forghani B; Grose C
    J Virol; 1993 Jan; 67(1):305-14. PubMed ID: 8380078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription mapping of glycoprotein I (gpI) and gpIV of varicella-zoster virus and immunological analysis of the gpI produced in cells infected with the recombinant vaccinia virus.
    Kato T; Kitamura K; Hayakawa Y; Takahashi M; Kojima A; Sato S; Yamanishi K
    Microbiol Immunol; 1989; 33(4):299-312. PubMed ID: 2549343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.
    Lowry PW; Solem S; Watson BN; Koropchak CM; Thackray HM; Kinchington PR; Ruyechan WT; Ling P; Hay J; Arvin AM
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():811-9. PubMed ID: 1321876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Existence of similar antigenic-sites on varicella-zoster virus gpI and gpIV.
    Vafai A; Jensen K; Kubo R
    Virus Res; 1989 Aug; 13(4):319-36. PubMed ID: 2479191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific lysis of targets expressing varicella-zoster virus gpI or gpIV by CD4+ human T-cell clones.
    Huang Z; Vafai A; Lee J; Mahalingam R; Hayward AR
    J Virol; 1992 May; 66(5):2664-9. PubMed ID: 1348545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional analysis of two simian varicella virus glycoprotein genes which are homologous to varicella-zoster virus gpI (gE) and gpIV (gI).
    Fletcher TM; Gray WL
    Virology; 1994 Nov; 205(1):352-9. PubMed ID: 7975231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant.
    Ludvíková V; Kunke D; Hamsíková E; Kutinová L; Vonka V
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1445-9. PubMed ID: 1646285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of similar epitopes on varicella-zoster virus gpI and gpIV by monoclonal antibodies.
    Vafai A; Wroblewska Z; Mahalingam R; Cabirac G; Wellish M; Cisco M; Gilden D
    J Virol; 1988 Aug; 62(8):2544-51. PubMed ID: 2455814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka).
    Kinchington PR; Ling P; Pensiero M; Moss B; Ruyechan WT; Hay J
    J Virol; 1990 Sep; 64(9):4540-8. PubMed ID: 2166829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of antibody against in vitro translation products encoded by varicella-zoster virus glycoprotein genes.
    Vafai A; Wellish M; Wroblewska Z; Cisco M; Gilden D
    Virus Res; 1987 Jun; 7(4):325-33. PubMed ID: 3039752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI.
    Litwin V; Jackson W; Grose C
    J Virol; 1992 Jun; 66(6):3643-51. PubMed ID: 1316474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of varicella-zoster virus glycoprotein I in cells infected with a vaccinia virus recombinant.
    Cabirac G; Gilden D; Wellish M; Vafai A
    Virus Res; 1988 May; 10(2-3):205-13. PubMed ID: 2842971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenicity of a candidate varicella-zoster virus glycoprotein subunit vaccine.
    Vafai A
    Vaccine; 1993; 11(9):937-40. PubMed ID: 8212841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of neutralizing antibodies by varicella-zoster virus gpII glycoprotein expressed from recombinant vaccinia virus.
    Massaer M; Haumont M; Place M; Bollen A; Jacobs P
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():491-4. PubMed ID: 8383181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual phosphorylation sequence in the gpIV (gI) component of the varicella-zoster virus gpI-gpIV glycoprotein complex (VZV gE-gI complex).
    Yao Z; Grose C
    J Virol; 1994 Jul; 68(7):4204-11. PubMed ID: 8207795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with Varicella-zoster virus glycoprotein E expressing vectors: Comparison of antibody response to DNA vaccine and recombinant vaccinia virus.
    Stasíková J; Kutinová L; Smahel M; Nĕmecková S
    Acta Virol; 2003; 47(1):1-10. PubMed ID: 12828337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription from varicella-zoster virus gene 67 (glycoprotein IV).
    Ling P; Kinchington PR; Sadeghi-Zadeh M; Ruyechan WT; Hay J
    J Virol; 1992 Jun; 66(6):3690-8. PubMed ID: 1316476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-binding sites on truncated forms of varicella-zoster virus gpI(gE) glycoprotein.
    Vafai A
    Vaccine; 1994 Nov; 12(14):1265-9. PubMed ID: 7531921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.